TALPHERA, INC. Repayments of Long-Term Debt
TALPHERA, INC. (TLPH) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-03-31
- TALPHERA, INC. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00.
- TALPHERA, INC. repayments of long-term debt for the quarter ending 2024-09-30 was $0.00.
- TALPHERA, INC. repayments of long-term debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. repayments of long-term debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- TALPHERA, INC. repayments of long-term debt for fiscal 2023 was $5.42M, a 35.78% decline from fiscal 2022.
- TALPHERA, INC. repayments of long-term debt for fiscal 2022 was $8.43M.
- TALPHERA, INC. repayments of long-term debt for fiscal 2020 was $4.67M, a 34.50% increase from fiscal 2019.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 72 month | Repayments of Long-term Debt 75 month | Repayments of Long-term Debt 78 month | Repayments of Long-term Debt 81 month | Repayments of Long-term Debt 84 month | Repayments of Long-term Debt 87 month | Repayments of Long-term Debt 90 month | Repayments of Long-term Debt 93 month | Repayments of Long-term Debt 96 month | Repayments of Long-term Debt 99 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | ||||||||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-03-31 | ||||||||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 derived: sum of 4 quarters · filed 2025-03-31 | ||||||||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $3.33M derived: sum of 4 quarters · filed 2025-03-31 | ||||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $3.33M derived: sum of 3 quarters · filed 2025-03-31 | $5.42M 10-K · filed 2025-03-31 | ||||||||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.33M derived: sum of 2 quarters · filed 2024-11-13 | $5.42M 10-Q · filed 2024-11-13 | $7.60M derived: sum of 4 quarters · filed 2024-11-13 | ||||||||||
| 2023-06-30 | $3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $5.42M 10-Q · filed 2024-08-14 | $7.60M derived: sum of 3 quarters · filed 2024-08-14 | $9.68M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-14 | $4.27M derived: sum of 2 quarters · filed 2024-05-14 | $6.35M derived: sum of 3 quarters · filed 2024-05-14 | $8.43M derived: sum of 4 quarters · filed 2024-05-14 | ||||||||||
| 2022-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $4.27M derived: sum of 2 quarters · filed 2024-03-06 | $6.35M derived: sum of 3 quarters · filed 2024-03-06 | $8.43M 10-K · filed 2024-03-06 | ||||||||||
| 2022-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $4.17M derived: sum of 2 quarters · filed 2023-11-14 | $6.25M 10-Q · filed 2023-11-14 | $8.33M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||
| 2022-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.17M 10-Q · filed 2023-08-10 | $6.25M derived: sum of 3 quarters · filed 2023-08-10 | $8.83M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||
| 2022-03-31 | $2.08M 10-Q · filed 2023-05-10 | $4.17M derived: sum of 2 quarters · filed 2023-08-01 | $6.75M derived: sum of 3 quarters · filed 2023-08-01 | $8.83M derived: sum of 4 quarters · filed 2023-08-01 | ||||||||||
| 2021-12-31 | $2.08M derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | $4.67M derived: sum of 2 quarters · filed 2023-08-01 | $6.75M derived: sum of 3 quarters · filed 2023-08-01 | $8.83M 8-K · filed 2023-08-01 | ||||||||||
| 2021-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.67M derived: sum of 2 quarters · filed 2022-11-14 | $6.75M 10-Q · filed 2022-11-14 | $8.83M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $4.17M 10-Q · filed 2022-08-11 | $6.25M derived: sum of 3 quarters · filed 2022-08-11 | $8.83M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||
| 2021-03-31 | $2.08M 10-Q · filed 2022-05-16 | $4.17M derived: sum of 2 quarters · filed 2022-05-16 | $6.75M derived: sum of 3 quarters · filed 2022-05-16 | $6.75M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||
| 2020-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $4.67M derived: sum of 2 quarters · filed 2022-03-10 | $4.67M derived: sum of 3 quarters · filed 2022-03-10 | $4.67M 10-K · filed 2022-03-10 | ||||||||||
| 2020-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.58M derived: sum of 2 quarters · filed 2021-11-15 | $2.58M 10-Q · filed 2021-11-15 | $2.58M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2021-08-16 | $0.00 derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | $1.41M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $1.41M derived: sum of 3 quarters · filed 2021-03-15 | $3.47M 10-K · filed 2021-03-15 | ||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.41M derived: sum of 2 quarters · filed 2020-11-05 | $3.47M 10-Q · filed 2020-11-05 | $5.48M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||||
| 2019-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.47M 10-Q · filed 2020-08-10 | $5.48M derived: sum of 3 quarters · filed 2021-03-15 | $7.43M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||||
| 2019-03-31 | $2.06M 10-Q · filed 2020-05-11 | $4.07M derived: sum of 2 quarters · filed 2021-03-15 | $6.02M derived: sum of 3 quarters · filed 2021-03-15 | $7.92M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||||
| 2018-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.96M derived: sum of 2 quarters · filed 2021-03-15 | $5.86M derived: sum of 3 quarters · filed 2021-03-15 | $7.72M 10-K · filed 2021-03-15 | ||||||||||
| 2018-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.85M derived: sum of 2 quarters · filed 2019-11-07 | $5.71M 10-Q · filed 2019-11-07 | |||||||||||
| 2018-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.76M 10-Q · filed 2019-08-06 | ||||||||||||
| 2018-03-31 | $1.86M 10-Q · filed 2019-05-09 | |||||||||||||
| 2017-12-31 | $3.51M 10-K · filed 2020-03-16 | |||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.29M derived: sum of 2 quarters · filed 2018-03-09 | $4.53M 10-K · filed 2018-03-09 | |||||||||||
| 2015-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $4.53M 10-Q · filed 2016-11-02 | ||||||||||||
| 2015-06-30 | $2.24M 10-Q · filed 2016-07-29 | |||||||||||||
| 2013-12-31 | $10.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $12.53M derived: sum of 2 quarters · filed 2016-03-07 | $14.45M derived: sum of 3 quarters · filed 2016-03-07 | $16.34M 10-K · filed 2016-03-07 | ||||||||||
| 2013-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $3.90M derived: sum of 2 quarters · filed 2014-11-10 | $5.79M 10-Q · filed 2014-11-10 | $7.64M derived: sum of 4 quarters · filed 2015-03-13 | $22.66M 10-Q · filed 2013-11-05 | |||||||||
| 2013-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $3.82M 10-Q · filed 2014-08-11 | $5.67M derived: sum of 3 quarters · filed 2015-03-13 | $7.47M derived: sum of 4 quarters · filed 2015-03-13 | $20.70M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | $1.89M 10-Q · filed 2014-05-08 | $3.74M derived: sum of 2 quarters · filed 2015-03-13 | $5.55M derived: sum of 3 quarters · filed 2015-03-13 | $5.55M derived: sum of 4 quarters · filed 2015-03-13 | $18.77M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $3.65M derived: sum of 2 quarters · filed 2015-03-13 | $3.65M derived: sum of 3 quarters · filed 2015-03-13 | $3.65M 10-K · filed 2015-03-13 | $16.88M 10-K · filed 2013-03-12 | |||||||||
| 2012-09-30 | $1.81M derived: 10-Q 87 month − 10-Q 84 month · filed 2012-11-06 | $1.81M derived: sum of 2 quarters · filed 2012-11-06 | $1.81M 10-Q · filed 2013-11-05 | $1.80M derived: sum of 4 quarters · filed 2014-03-17 | $15.03M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 84 month − 10-Q 81 month · filed 2012-08-10 | $0.00 derived: sum of 2 quarters · filed 2012-08-10 | -$1.00K derived: sum of 3 quarters · filed 2014-03-17 | -$1.00K derived: sum of 4 quarters · filed 2014-03-17 | $13.22M 10-Q · filed 2012-08-10 | |||||||||
| 2012-03-31 | $0.00 derived: 10-Q 81 month − 10-K 78 month · filed 2012-05-09 | -$1.00K derived: sum of 2 quarters · filed 2014-03-17 | -$1.00K derived: sum of 3 quarters · filed 2014-03-17 | $4.05M derived: sum of 4 quarters · filed 2014-03-17 | $13.22M 10-Q · filed 2012-05-09 | |||||||||
| 2011-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$1.00K derived: sum of 2 quarters · filed 2014-03-17 | $4.05M derived: sum of 3 quarters · filed 2014-03-17 | $5.30M 10-K · filed 2014-03-17 | $13.22M 10-K · filed 2012-03-23 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $4.05M derived: sum of 2 quarters · filed 2012-11-06 | $5.30M 10-Q · filed 2012-11-06 | $6.52M derived: sum of 4 quarters · filed 2013-03-12 | $13.22M 10-Q · filed 2011-11-08 | |||||||||
| 2011-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $5.30M 10-Q · filed 2012-08-10 | $6.52M derived: sum of 3 quarters · filed 2013-03-12 | $7.71M derived: sum of 4 quarters · filed 2013-03-12 | $13.22M 10-Q · filed 2011-08-11 | |||||||||
| 2011-03-31 | $1.25M 10-Q · filed 2012-05-09 | $2.46M derived: sum of 2 quarters · filed 2013-03-12 | $3.66M derived: sum of 3 quarters · filed 2013-03-12 | |||||||||||
| 2010-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $2.41M derived: sum of 2 quarters · filed 2013-03-12 | $4.73M 10-K · filed 2013-03-12 | |||||||||||
| 2010-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $3.51M 10-Q · filed 2011-11-08 | ||||||||||||
| 2010-06-30 | $2.31M 10-Q · filed 2011-08-11 | |||||||||||||
| 2009-12-31 | $2.86M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |